For the quarter ending 2026-03-31, CSTL made $83,679K in revenue. -$14,522K in net income. Net profit margin of -17.35%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net revenues | 83,679 | 87,010 | 83,043 | 86,188 |
| Cost of sales (exclusive of amortization of acquired intangible assets) | 20,533 | 18,315 | 18,704 | 17,626 |
| Research and development | 14,428 | 13,515 | 12,960 | 12,787 |
| Selling, general and administrative | 64,899 | 56,731 | 55,907 | 58,065 |
| Amortization of acquired intangible assets | 2,226 | 2,276 | 2,276 | 1,961 |
| Total operating expenses, net | 102,086 | 90,837 | 89,847 | 90,439 |
| Operating loss | -18,407 | -3,827 | -6,804 | -4,251 |
| Interest income | 2,545 | 2,896 | 2,833 | 2,944 |
| Changes in fair value of equity securities | - | - | 3,561 | 1,185 |
| Net gains (losses) on equity securities | 2,022 | -1,759* | - | - |
| Interest expense | 134 | 24 | 24 | 21 |
| Other loss | -439 | 0* | 48 | - |
| Loss before income taxes | -14,413 | -2,714 | -386 | -143 |
| Income tax expense (benefit) | 109 | -382 | 115 | -4,666 |
| Net loss | -14,522 | -2,332 | -501 | 4,523 |
| Basic EPS | -0.49 | -0.079 | -0.02 | 0.16 |
| Diluted EPS | -0.49 | -0.081 | -0.02 | 0.15 |
| Basic Average Shares | 29,889,000 | 29,348,000 | 29,073,000 | 28,914,000 |
| Diluted Average Shares | 29,889,000 | 28,717,000 | 29,073,000 | 29,545,000 |
CASTLE BIOSCIENCES INC (CSTL)
CASTLE BIOSCIENCES INC (CSTL)